Ketrodex Eye Drop is a combination ophthalmic solution containing Ketorolac Tromethamine and Dexamethasone, formulated to provide effective anti-inflammatory and analgesic effects for ocular conditions. Ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation and pain. Dexamethasone, a potent corticosteroid, exerts strong anti-inflammatory and immunosuppressive actions by modulating the expression of inflammatory mediators and stabilizing cellular membranes. Ketrodex Eye Drop is indicated for the management of postoperative inflammation following ocular surgery, allergic conjunctivitis, and other inflammatory eye disorders where both inflammation and pain require simultaneous control. The combination therapy offers enhanced efficacy by targeting multiple pathways involved in ocular inflammation. It is typically administered topically as directed by an ophthalmologist, with dosage adjusted according to the severity of the condition. Caution is advised in patients with active ocular infections, glaucoma, or hypersensitivity to any component. Prolonged use may increase the risk of elevated intraocular pressure and cataract formation; therefore, regular monitoring is recommended. Ketrodex Eye Drop should be used under strict medical supervision to ensure optimal therapeutic outcomes and minimize potential adverse effects.